Cover Image
市場調查報告書

次世代定序市場分析:各技術 (全基因定序,全外顯子測序,標的定序,再定序),工作流程別 (NGSpre定序,NGS定序,NGS資料分析),及2022年前的市場區隔預測

Next Generation Sequencing Market Analysis By Application, Technology (Whole Genome Sequencing, Whole Exon Sequencing, Targeted Sequencing & Resequencing), Workflow (NGS Pre-Sequencing, NGS Sequencing, NGS Data Analysis) And Segment Forecasts To 2022

出版商 Grand View Research, Inc. 商品編碼 342362
出版日期 內容資訊 英文 111 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
次世代定序市場分析:各技術 (全基因定序,全外顯子測序,標的定序,再定序),工作流程別 (NGSpre定序,NGS定序,NGS資料分析),及2022年前的市場區隔預測 Next Generation Sequencing Market Analysis By Application, Technology (Whole Genome Sequencing, Whole Exon Sequencing, Targeted Sequencing & Resequencing), Workflow (NGS Pre-Sequencing, NGS Sequencing, NGS Data Analysis) And Segment Forecasts To 2022
出版日期: 2015年06月01日 內容資訊: 英文 111 Pages
簡介

全球次世代定序市場預測將在2020年前達到278億7,000萬美元。由於基因定序領域上的技術發展降低了標的定序成本,而促使了次世代定序的引進普及化。此外癌症和感染疾病的發病率上升也促使該市場成長加速的要素。

本報告提供全球次世代定序市場相關分析,彙整各技術,工作流程別預測,以及各地區趨勢等資料。

第1章 摘要整理

第3章 次世代定序產業預測

  • 市場區隔
  • 市場規模與成長預測
  • 市場趨勢
    • 促進要素
    • 阻礙要素
  • 產業分析
  • 優先的主要機會及平台定位
  • PESTEL分析
  • 企業市場佔有率分析
  • 產品及競爭環境分析

第3章 各用途預測

  • HLA檢驗
  • 產前檢查
  • 腫瘤學
  • 特發性疾病
  • 感染疾病

第4章 各技術預測

  • 全基因定序
  • 全外顯子測序
  • 標的定序及再定序

第5章 工作流程別預測

  • NGSpre定序
  • NGS定序
  • NGS資料分析

第6章 各地區預測

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第7章 競爭環境

  • Illumina, Inc.
  • 454 Life Sciences Corporation
  • Agilent Technologies, Inc.
  • BGI (Beijing Genomics Institute)
  • Biomatters, Ltd.
  • CLC bio (Acquired By Qiagen)
  • DNASTAR, Inc.
  • GATC Biotech Ag
  • Genomatix Software GmbH
  • Knome, Inc.
  • Life Technologies Corporation (Thermo Fisher Scientific)
  • Macrogen, Inc.
  • Oxford Nanopore Technologies, Ltd.
  • Pacific Biosciences
  • Partek Incorporated
  • Perkin Elmer, Inc.
  • Qiagen N.V.

圖表

目錄

The global market for next generation sequencing is expected to reach USD 27.87 billion by 2022. Technological developments in the field of genomic sequencing is expected to cause a decline in the cost of sequencing per base pair and thereby, greatly enhance adoption and usage rates of next generation sequencing over the forecast period. With this expected increase in usage of whole genome sequencing, a consequent increase in revenue from HLA and prenatal testing segments is also expected, owing to the introduction of more informative novel phase resolved single cycle reads. Growing incidences of cancer and infectious diseases are further expected to fuel the growth of the next generation sequencing market over the forecast period.

Further key findings from the study suggest:

Targeted sequencing & resequencing was the leading technology segment of the market in 2014, majorly owing to rapidly growing demand in oncology and infectious diseases related research. Sequencing of targeted genes allows researchers to gain insights into the functioning of cancer cells and pathogenic life cycles. Growing incidences of life threatening forms of cancer and infectious diseases is a high impact rendering factor expected to contribute to the growth of this segment over the forecast period.

The next generation sequencing based oncology market is expected to lead the market in terms of revenue throughout the forecast period. However, the use of NGS in fields of HLA and prenatal testing are expected to grow at a relatively higher rate through to 2022, owing to the introduction of techniques which can enable researchers to acquire phase-resolved HLA and prenatal sequences in single cycle reads. In addition, recent developments are expected to solve sequencing ambiguity issues and provide greater insights about genetic functioning.

Next generation sequencing was the largest workflow segment of the market in 2014. The introduction of technologically advanced genome sequencing platforms and the growing demand for personalized medicine are two factors likely to drive segment growth over the forecast period.

Next generation sequencing based data analysis is also expected to grow at a considerably high rate during the forecast period. Large amounts of sequencing data generated from extensive R&D initiatives and the subsequent growth in demand for storage and analysis are some factors attributing to the segment's rapid growth.

North America emerged as the leading regional market in 2014. High R&D investment directed towards the development of genome sequencing, presence of sophisticated technology framework, increasing adoption rates of whole genome sequencing and the reduction in cost of sequencing per base pair are some factors accounting for the region's large market share.

Key participants of the next generation sequencing market include GATC Biotech AG., Life Technologies (Thermo Fisher Scientific), 454 Life Sciences Corp. (Roche Holding AG), Pacific Biosciences, Agilent Technologies Inc., Macrogen Inc., Beijing Genomics Institute, Biomatters Ltd., CLC bio (Qiagen), Illumina Inc., DNASTAR Inc., Knome Inc., Qiagen NV., Helicos BioSciences, and Oxford Nanopore Technologies.

For the purpose of this study, Grand View Research has segmented the next generation sequencing market on the basis of technology, workflow, application and region:

Global Next Generation Sequencing Application Outlook (Revenue, USD Billion, 2012 - 2022)

  • HLA Testing
  • Prenatal Testing
  • Oncology
  • Idiopathic Diseases
  • Infectious Diseases
  • Others

Global Next Generation Sequencing Technology Outlook (Revenue, USD Billion, 2012 - 2022)

  • Whole Genome Sequencing
  • Whole Exon Sequencing
  • Targeted Sequencing & Resequencing

Global Next Generation Sequencing Workflow Outlook (Revenue, USD Billion, 2012 - 2022)

  • NGS Pre-sequencing
  • NGS Sequencing
  • NGS Data Analysis

Next Generation Sequencing Regional Outlook (Revenue, USD Billion, 2012 - 2022)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
  • MEA
    • South Africa

Table of Content

Chapter 1. Executive Summary

  • 1.1. Next Generation Sequencing - Industry Snapshot and Key Buying Criteria, 2012 - 2022

Chapter 2. Next Generation Sequencing Industry Outlook

  • 2.1. Market Segmentation
  • 2.2. Market Size and Growth Prospects
  • 2.3. Next Generation Sequencing Market Dynamics
    • 2.3.1. Market Driver Analysis
    • 2.3.2. Market Restraint Analysis
  • 2.4. Industry Analysis - Porter's
  • 2.5. Key Opportunities Prioritized & Platform Positioning
    • 2.5.1. Key Opportunities Prioritized
    • 2.5.2. NGS Platform Positioning
  • 2.6. Next Generation Sequencing Market PESTEL Analysis, 2014
  • 2.7. Company Market Share Analysis, 2014
  • 2.8. Product and competitive landscape analysis
    • 2.8.1. Penetration levels
    • 2.8.2. Comparative analysis
    • 2.8.3. Application areas

Chapter 3. Next Generation Sequencing Application Outlook

  • 3.1. HLA Testing
    • 3.1.1. HLA Testing Market Estimates and Forecasts, 2012 - 2022 (USD Billion)
  • 3.2. Prenatal Testing
    • 3.2.1. Prenatal Testing Market Estimates and Forecasts, 2012 - 2022 (USD Billion)
  • 3.3. Oncology
    • 3.3.1. Oncology Market Estimates and Forecasts, 2012 - 2022 (USD Billion)
  • 3.4. Idiopathic Diseases
    • 3.4.1. Idiopathic Diseases Market Estimates and Forecasts, 2012 - 2022 (USD Billion)
  • 3.5. Infectious Diseases
    • 3.5.1. Infectious Diseases Market Estimates and Forecasts, 2012 - 2022 (USD Billion)

Chapter 4. Next Generation Sequencing Technology Outlook

  • 4.1. Whole Genome Sequencing
    • 4.1.1. Whole Genome Sequencing Market Estimates and Forecasts, 2012 - 2022 (USD Billion)
  • 4.2. Whole Exon Sequencing
    • 4.2.1. Whole Exon Sequencing Market Estimates and Forecasts, 2012 - 2022 (USD Billion)
  • 4.3. Targeted Sequencing & Resequencing
    • 4.3.1. Targeted Sequencing & Resequencing Market Estimates and Forecasts, 2012 - 2022 (USD Billion)

Chapter 5. Next Generation Sequencing Workflow Outlook

  • 5.1. NGS Pre-sequencing
    • 5.1.1. NGS Pre-sequencing Market Estimates and Forecasts, 2012 - 2022 (USD Billion)
  • 5.2. NGS Sequencing
    • 5.2.1. NGS Sequencing Market Estimates and Forecasts, 2012 - 2022 (USD Billion)
  • 5.3. NGS Data Analysis
    • 5.3.1. NGS Data Analysis Market Estimates and Forecasts, 2012 - 2022 (USD Billion)

Chapter 6. Next Generation Sequencing Regional Outlook

  • 6.1. North America
    • 6.1.1. U.S.
      • 6.1.1.1. U.S. Next Generation Sequencing Market, by Application, 2012 - 2022 (USD Billion)
      • 6.1.1.2. U.S. Next Generation Sequencing Market, by Technology, 2012 - 2022 (USD Billion)
      • 6.1.1.3. U.S. Next Generation Sequencing Market, by Workflow, 2012 - 2022 (USD Billion)
    • 6.1.2. Canada
      • 6.1.2.1. Canada Next Generation Sequencing Market, by Application, 2012 - 2022 (USD Billion)
      • 6.1.2.2. Canada Next Generation Sequencing Market, by Technology, 2012 - 2022 (USD Billion)
      • 6.1.2.3. Canada Next Generation Sequencing Market, by Workflow, 2012 - 2022 (USD Billion)
  • 6.2. Europe
    • 6.2.1. Germany
      • 6.2.1.1. Germany Next Generation Sequencing Market, by Application, 2012 - 2022 (USD Billion)
      • 6.2.1.2. Germany Next Generation Sequencing Market, by Technology, 2012 - 2022 (USD Billion)
      • 6.2.1.3. Germany Next Generation Sequencing Market, by Workflow, 2012 - 2022 (USD Billion)
    • 6.2.2. UK
      • 6.2.2.1. UK Next Generation Sequencing Market, by Application, 2012 - 2022 (USD Billion)
      • 6.2.2.2. UK Next Generation Sequencing Market, by Technology, 2012 - 2022 (USD Billion)
      • 6.2.2.3. UK Next Generation Sequencing Market, by Workflow, 2012 - 2022 (USD Billion)
  • 6.3. Asia Pacific
    • 6.3.1. Japan
      • 6.3.1.1. Japan Next Generation Sequencing Market, by Application, 2012 - 2022 (USD Billion)
      • 6.3.1.2. Japan Next Generation Sequencing Market, by Technology, 2012 - 2022 (USD Billion)
      • 6.3.1.3. Japan Next Generation Sequencing Market, by Workflow, 2012 - 2022 (USD Billion)
    • 6.3.2. China
      • 6.3.2.1. China Next Generation Sequencing Market, by Application, 2012 - 2022 (USD Billion)
      • 6.3.2.2. China Next Generation Sequencing Market, by Technology, 2012 - 2022 (USD Billion)
      • 6.3.2.3. China Next Generation Sequencing Market, by Workflow, 2012 - 2022 (USD Billion)
  • 6.4. Latin America
    • 6.4.1. Brazil
      • 6.4.1.1. Brazil Next Generation Sequencing Market, by Application, 2012 - 2022 (USD Billion)
      • 6.4.1.2. Brazil Next Generation Sequencing Market, by Technology, 2012 - 2022 (USD Billion)
      • 6.4.1.3. Brazil Next Generation Sequencing Market, by Workflow, 2012 - 2022 (USD Billion)
  • 6.5. MEA
    • 6.5.1. South Africa
      • 6.5.1.1. South Africa Next Generation Sequencing Market, by Application, 2012 - 2022 (USD Billion)
      • 6.5.1.2. South Africa Next Generation Sequencing Market, by Technology, 2012 - 2022 (USD Billion)
      • 6.5.1.3. South Africa Next Generation Sequencing Market, by Workflow, 2012 - 2022 (USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Illumina, Inc.
    • 7.1.1. Company Overview
    • 7.1.2. Revenue Analysis
    • 7.1.3. Product Benchmarking
    • 7.1.4. Strategic Development
  • 7.2. 454 Life Sciences Corporation (Roche Holding Ag)
    • 7.2.1. Company Overview
    • 7.2.2. Revenue Analysis
    • 7.2.3. Product Benchmarking
    • 7.2.4. Strategic Development
  • 7.3. Agilent Technologies, Inc.
    • 7.3.1. Company Overview
    • 7.3.2. Revenue Analysis
    • 7.3.3. Product Benchmarking
    • 7.3.4. Strategic Development
  • 7.4. BGI (Beijing Genomics Institute)
    • 7.4.1. Company Overview
    • 7.4.2. Revenue Analysis
    • 7.4.3. Product Benchmarking
    • 7.4.4. Strategic Development
  • 7.5. Biomatters, Ltd.
    • 7.5.1. Company Overview
    • 7.5.2. Revenue Analysis
    • 7.5.3. Product Benchmarking
    • 7.5.4. Strategic Development
  • 7.6. CLC bio (Acquired By Qiagen)
    • 7.6.1. Company Overview
    • 7.6.2. Revenue Analysis
    • 7.6.3. Product Benchmarking
    • 7.6.4. Strategic Development
  • 7.7. DNASTAR, Inc.
    • 7.7.1. Company Overview
    • 7.7.2. Revenue Analysis
    • 7.7.3. Product Benchmarking
    • 7.7.4. Strategic Development
  • 7.8. GATC Biotech Ag
    • 7.8.1. Company Overview
    • 7.8.2. Revenue Analysis
    • 7.8.3. Product Benchmarking
    • 7.8.4. Strategic Development
  • 7.9. Genomatix Software GmbH
    • 7.9.1. Company Overview
    • 7.9.2. Revenue Analysis
    • 7.9.3. Product Benchmarking
    • 7.9.4. Strategic Development
  • 7.10. Knome, Inc.
    • 7.10.1. Company Overview
    • 7.10.2. Revenue Analysis
    • 7.10.3. Product Benchmarking
    • 7.10.4. Strategic Development
  • 7.11. Life Technologies Corporation (Thermo Fisher Scientific)
    • 7.11.1. Company Overview
    • 7.11.2. Revenue Analysis
    • 7.11.3. Product Benchmarking
    • 7.11.4. Strategic Development
  • 7.12. Macrogen, Inc.
    • 7.12.1. Company Overview
    • 7.12.2. Revenue Analysis
    • 7.12.3. Product Benchmarking
    • 7.12.4. Strategic Development
  • 7.13. Oxford Nanopore Technologies, Ltd.
    • 7.13.1. Company Overview
    • 7.13.2. Revenue Analysis
    • 7.13.3. Product Benchmarking
    • 7.13.4. Strategic Development
  • 7.14. Pacific Biosciences
    • 7.14.1. Company Overview
    • 7.14.2. Revenue Analysis
    • 7.14.3. Product Benchmarking
    • 7.14.4. Strategic Development
  • 7.15. Partek Incorporated
    • 7.15.1. Company Overview
    • 7.15.2. Revenue Analysis
    • 7.15.3. Product Benchmarking
    • 7.15.4. Strategic Development
  • 7.16. Perkin Elmer, Inc.
    • 7.16.1. Company Overview
    • 7.16.2. Revenue Analysis
    • 7.16.3. Product Benchmarking
    • 7.16.4. Strategic Development
  • 7.17. Qiagen N.V.
    • 7.17.1. Company Overview
    • 7.17.2. Revenue Analysis
    • 7.17.3. Product Benchmarking
    • 7.17.4. Strategic Development

List of Tables

  • 1. Next generation sequencing Market - Industry Summary & Key Buying Criteria
  • 2. Next generation sequencing market, by application, 2012 - 2022 (USD Billion)
  • 3. Next generation sequencing market, by technology, 2012 - 2022 (USD Billion)
  • 4. Next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
  • 5. Next generation sequencing market, by region, 2012 - 2022 (USD Billion)
  • 6. Next generation sequencing - Key market driver analysis
  • 7. Next generation sequencing - Key market restraint analysis
  • 8. Rating scale for platform positioning
  • 9. North America market, by application, 2012 - 2022 (USD Billion)
  • 10. North America market, by technology, 2012 - 2022 (USD Billion)
  • 11. North America market, by workflow, 2012 - 2022 (USD Billion)
  • 12. U.S. next generation sequencing market, by application, 2012 - 2022 (USD Billion)
  • 13. U.S. next generation sequencing market, by technology, 2012 - 2022 (USD Billion)
  • 14. U.S. next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
  • 15. Canada next generation sequencing market, by application, 2012 - 2022 (USD Billion)
  • 16. Canada next generation sequencing market, by technology, 2012 - 2022 (USD Billion)
  • 17. Canada next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
  • 18. Europe next generation sequencing market, by application, 2012 - 2022 (USD Billion)
  • 19. Europe next generation sequencing market, by technology, 2012 - 2022 (USD Billion)
  • 20. Europe next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
  • 21. Germany next generation sequencing market, by application, 2012 - 2022 (USD Billion)
  • 22. Germany next generation sequencing market, by technology, 2012 - 2022 (USD Billion)
  • 23. Germany next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
  • 24. UK next generation sequencing market, by application, 2012 - 2022 (USD Billion)
  • 25. UK next generation sequencing market, by technology, 2012 - 2022 (USD Billion)
  • 26. UK next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
  • 27. Asia Pacific market, by application, 2012 - 2022 (USD Billion)
  • 28. Asia Pacific market, by technology, 2012 - 2022 (USD Billion)
  • 29. Asia Pacific next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
  • 30. Japan next generation sequencing market, by application, 2012 - 2022 (USD Billion)
  • 31. Japan next generation sequencing market, by technology, 2012 - 2022 (USD Billion)
  • 32. Japan next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
  • 33. China next generation sequencing market, by application, 2012 - 2022 (USD Billion)
  • 34. China next generation sequencing market, by technology, 2012 - 2022 (USD Billion)
  • 35. China next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
  • 36. Latin America market, by application, 2012 - 2022 (USD Billion)
  • 37. Latin America market, by technology, 2012 - 2022 (USD Billion)
  • 38. Latin America market, by workflow, 2012 - 2022 (USD Billion)
  • 39. Brazil next generation sequencing market, by application, 2012 - 2022 (USD Billion)
  • 40. Brazil next generation sequencing market, by technology, 2012 - 2022 (USD Billion)
  • 41. Brazil next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
  • 42. MEA next generation sequencing market, by application, 2012 - 2022 (USD Billion)
  • 43. MEA next generation sequencing market, by technology, 2012 - 2022 (USD Billion)
  • 44. MEA next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)
  • 45. South Africa market, by application, 2012 - 2022 (USD Billion)
  • 46. South Africa market, by technology, 2012 - 2022 (USD Billion)
  • 47. South Africa next generation sequencing market, by workflow, 2012 - 2022 (USD Billion)

List of Figures

  • 1. Next Generation Sequencing: Market segmentation
  • 2. Global next generation sequencing market, (USD Billion), 2012 - 2022
  • 3. Next generation sequencing: Market dynamics
  • 4. Next generation sequencing market - Porter's Analysis
  • 5. Key opportunities prioritized 2014
  • 6. NGS Platform positioning
  • 7. Next generation sequencing market - PESTEL analysis
  • 8. Next generation sequencing: Company market share analysis, 2014
  • 9. Next generation sequencing market share, by application, 2014 & 2022
  • 10. Global HLA testing market, 2012 - 2022 (USD Billion)
  • 11. Global prenatal testing market, 2012 - 2022 (USD Billion)
  • 12. Global oncology market, 2012 - 2022 (USD Billion)
  • 13. Global idiopathic diseases market, 2012 - 2022 (USD Billion)
  • 14. Global infectious diseases market, 2012 - 2022 (USD Billion)
  • 15. Next generation sequencing market share by technology, 2014 & 2022
  • 16. Global whole genome sequencing market, 2012 - 2022 (USD Billion)
  • 17. Global whole exon sequencing market, 2012 - 2022 (USD Billion)
  • 18. Global panel sequencing & resequencig market, 2012 - 2022 (USD Billion)
  • 19. Next generation sequencing market share by workflow, 2014 & 2022
  • 20. Global NGS pre-sequencing market, 2012 - 2022 (USD Billion)
  • 21. Global NGS sequencing market, 2012 - 2022 (USD Billion)
  • 22. Global NGS data analysis market, 2012 - 2022 (USD Billion)
  • 23. North America next generation sequencing market, 2012 - 2022 (USD Billion)
  • 24. U.S. next generation sequencing market, 2012 - 2022 (USD Billion)
  • 25. Canada next generation sequencing market, 2012 - 2022 (USD Billion)
  • 26. Europe next generation sequencing market, 2012 - 2022 (USD Billion)
  • 27. Germany next generation sequencing market, 2012 - 2022 (USD Billion)
  • 28. UK next generation sequencing market, 2012 - 2022 (USD Billion)
  • 29. Asia Pacific next generation sequencing market, 2012 - 2022 (USD Billion)
  • 30. Japan next generation sequencing market, 2012 - 2022 (USD Billion)
  • 31. China next generation sequencing market, 2012 - 2022 (USD Billion)
  • 32. Latin America next generation sequencing market, 2012 - 2022 (USD Billion)
  • 33. Brazil next generation sequencing market, 2012 - 2022 (USD Billion)
  • 34. MEA next generation sequencing market, 2012 - 2022 (USD Billion)
  • 35. South Africa next generation sequencing market, 2012 - 2022 (USD Billion)
Back to Top